Omega-3 fatty acids: Anti-arrhythmic, pro-arrhythmic, or both?

Frontiers in Physiology

Volumn 3 APR, Issue , 2012, Pages

  von Schacky, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atrial fibrillation; Docosahexaenoic acid; Eicosapentaenoic acid; Omega 3 fatty acids; Omega 3 index; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

EID: 84865217857     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00088     Document Type: Review

References (89)

1. Aarsetoey, H., Aarsetoey, R., Lindner, T., Staines, H., Harris, W. S., and Nilsen, D. W. (2011). Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids 46, 151-161.
2. Aarsetoey, H., Pönitz, V., Nilsen, O. B., Grundt, H., Harris, W. S., and Nilsen, D. W. (2008). Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation 78, 258-264.
3. Abdukeyum, G. G., Owen, A. J., and McLennan, P. L. (2008). Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J. Nutr. 138, 1902-1909.
4. Bacova, B., Radosinska, J., Knezl, V., Kolenova, L., Weismann, P., Navarova, J., Barancik, M., Mitasikova, M., and Tribulova, N. (2010). Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J. Physiol. Pharmacol. 61, 717-723.
5. Berry, J. D., Prineas, R. J., van Horn, L., Passman, R., Larson, J., Goldberger, J., Snetselaar, L., Tinker, L., Liu, K., and Lloyd-Jones, D. M. (2010). Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). Am. J. Cardiol. 105, 844-848.
6. Bianconi, L., Calò, L., Mennuni, M., Santini, L., Morosetti, P., Azzolini, P., Barbato, G., Biscione, F., Romano, P., and Santini, M. (2011). n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study. Europace 13, 174-181.
7. Billman, G. E., and Harris, W. S. (2011). Effect of dietary omega-3 fatty acids on the heart rate and the heart rate variability responses to myocardial ischemia or submaximal exercise. Am. J. Physiol. Heart Circ. Physiol. 300, H2288-H2299.
8. Billman, G. E., Harris, W. S., Carnes, C. A., Adamson, P. B., Vanoli, E., and Schwartz, P. J. (2012). Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: Lack of protection and A proarrhythmic effect. Circ. Arrhythm. Electrophysiol. [Epub ahead of print].
9. Billman, G. E., Nishijima, Y., Belevych, A. E., Terentyev, D., Xu, Y., Haizlip, K. M., Monasky, M. M., Hiranandani, N., Harris, W. S., Gyorke, S., Carnes, C. A., and Janssen, P. M. (2010). Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. Am. J. Physiol. Heart Circ. Physiol. 298, H1219-H1228.
10. Block, R. C., Harris, W. S., Reid, K. J., Sands,S.A.,and Spertus,J.A. (2008). EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197, 821-828.
11. Brouwer, I. A., Raitt, M. H., Dullemeijer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., and McAnulty, J. (2010). Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur. Heart J. 30, 820-826.
12. Calò, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M. L., de Ruvo, E., Meo, A., Pandozi, C., Staibano, M., and Santini, M. (2005). N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol. 45, 1723-1728.
13. De Caterina, R. (2011). N-3 fatty acids in cardiovascular disease. N. Engl. J. Med. 364, 2439-2450.
14. Den Ruijter, H. M., Berecki, G., Verkerk, A. O., Bakker, D., Baartscheer, A., Schumacher, C. A., Belterman, C. N., de Jonge, N., Fiolet, J. W., Brouwer, I. A., and Coronel, R. (2008). Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 117, 536-544.
15. Den Ruijter, H. M., Verkerk, A. O., and Coronel, R. (2010). Incorporated fish oil fatty acids prevent action potential shortening induced by circulating fish oil fatty acids. Front. Physiol. 1:149. doi:10.3389/fphys.2010.00149
16. Dujardin, K. S., Dumotier, B., David, M., Guizy, M., Valenzuela, C., and Hondeghem, L. M. (2008). Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts. Am. J. Physiol. Heart Circ. Physiol. 295, H1414-H1421.
17. Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., and Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot. Essent. Fatty Acids 83, 137-141.
18. Ebbesson, S. O., Devereux, R. B., Cole, S., Ebbesson, L. O., Fabsitz, R. R., Haack, K., Harris, W. S., Howard, W. J., Laston, S., Lopez-Alvarenga, J. C., MacCluer, J. W., Okin, P. M., Tejero, M. E., Voruganti, V. S., Wenger, C. R., Howard, B. V., and Comuzzie, A. G. (2010). Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) Study. Am.HeartJ. 159, 1020-1025.
19. Eckel, R. H. (2010). The fish oil story remains fishy. Circulation 122, 2110-2112.
20. Falck, J. R., Wallukat, G., Puli, N., Goli, M., Arnold, C., Konkel, A., Rothe, M., Fischer, R., Müller, D. N., and Schunck, W. H. (2011). 17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues. J. Med. Chem. 54, 4109-4118.
21. Farquharson, A. L., Metcalf, R. G., Sanders, P., Stuklis, R., Edwards, J. R., Gibson, R. A., Cleland, L. G., Sullivan, T. R., James, M. J., and Young, G. D. (2011). Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am. J. Cardiol. 108, 851-856.
22. Finzi, A. A., Latini, R., Barlera, S., Rossi, M. G., Ruggeri, A., Mezzani, A., Favero, C., Franzosi, M. G., Serra, D., Lucci, D., Bianchini, F., Bernasconi, R., Maggioni, A. P., Nicolosi, G., Porcu, M., Tognoni, G., Tavazzi, L., and Marchioli, R. (2011). Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverterdefibrillators: a substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Am. Heart J. 161, 338-343.
23. Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., and SU.FOL.OM3 Collaborative Group. (2010). Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 341, c6273.
24. Geleijnse, J. M., Giltay, E. J., Schouten, E. G., de Goede, J., Oude Griep, L. M., Teitsma-Jansen, A. M., Katan, M. B., and Kromhout, D. (2010). Alpha Omega Trial Group. Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial. Am. Heart J. 159, 539-546.
25. Gissi-HF Investigators, Tavazzi, L., Maggioni, A. P., Marchioli, R., Barlera, S., Franzosi, M. G., Latini, R., Lucci, D., Nicolosi, G. L., Porcu, M., and Tognoni, G. (2008). Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230.
26. Gronroos, N. N., and Alonso, A. (2010). Diet and risk of atrial fibrillation - epidemiologic and clinical evidence. Circ. J. 74, 2029-2038.
27. Harris, W. S., and Thomas, R. M. (2010). Biological variability of blood omega-3 biomarkers. Clin. Biochem. 43, 338-340.
28. Harris, W. S., and von Schacky, C. (2004). The omega-3 index: a new risk factor for death from coronary heart disease? Prev. Med. 39, 212-220.
29. Heidarsdottir, R., Arnar, D. O., Skuladottir, G. V., Torfason, B., Edvardsson, V., Gottskalksson, G., Palsson, R., and Indridason, O. S. (2010). Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 12, 356-363.
30. Heidt, M. C., Vician, M., Stracke, S. K., Stadlbauer, T., Grebe, M. T., Boening, A., Vogt, P. R., and Erdogan, A. (2009). Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac. Cardiovasc. Surg. 57, 276-280.
31. Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., and Humphrey, L. L. (2009). Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann. Intern. Med. 151, 496-507.
32. Hlatky, M. A., Greenland, P., Arnett, D. K., Ballantyne, C. M., Criqui, M. H., Elkind, M. S., Go, A. S., Harrell, F.E. Jr., Hong, Y., Howard, B. V., Howard, V. J., Hsue, P. Y., Kramer, C. M., McConnell, J. P., Normand, S. L., O'Donnell, C. J., Smith, S. C. Jr., and Wilson, P. W. (2009). American Heart Association expert panel on subclinical atherosclerotic diseases and emerging risk factors and the Stroke Council. Circulation 119, 2408-2416.
33. Huggins, C. E., Curl, C. L., Patel, R., McLennan, P. L., Theiss, M. L., Pedrazzini, T., Pepe, S., and Delbridge, L. M. (2009). Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice. Am. J. Physiol. Heart Circ. Physiol. 296, H957-H966.
34. Kitamura, K., Shibata, R., Tsuji, Y., Shimano, M., Inden, Y., and Murohara, T. (2011). Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model. Am. J. Physiol. Heart Circ. Physiol. 300, H1814-H1821.
35. Köhler, A., Bittner, D., Löw, A., and von Schacky, C. (2010). Effects of a convenience drink fortified with n3 fatty acids on the n-3 index. Br. J. Nutr. 104, 729-736.
36. Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., and Pratt, C. M. (2010). Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. J. Am. Med. Assoc. 304, 2363-2372.
37. Kromhout, D., Geleijnse, J. M., de Goede, J., Oude Griep, L. M., Mulder, B. J., de Boer, M. J., Deckers, J. W., Boersma, E., Zock, P. L., and Giltay, E. J. (2011). n-3 fatty acids, ventricular arrhythmiarelated events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 34, 2515-2520.
38. Kromhout, D., Giltay, E. J., Geleijnse, J. M., and Alpha Omega Trial Group. (2010). N-3 fatty acids and cardiovascular events after myocardial infarction. N.Engl.J.Med.363, 2015-2026.
39. Kumar, S., Sutherland, F., The, A. W., Heck, P. M., Lee, G., Garg, M. L., and Sparks, P. B. (2011a). Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. Am. J. Cardiol. 108, 531-535.
40. Kumar, S., Sutherland, F., Rosso, R., The, A. W., Lee, G., Heck, P. M., Feldman, A., Medi, C., Watt, S., Garg, M. L., and Sparks, P. B. (2011b). Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm 8, 562-568.
41. Kumar, S., Sutherland, F., Wheeler, M., Heck, P. M., Lee, G., The, A. W., Garg, M. L., Morgan, J. G., and Sparks, P. B. (2011c). Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial mechanical function after reversion of atrial arrhythmias to sinus rhythm: reversal of tachycardia-mediated atrial cardiomyopathy with fish oils. Heart Rhythm 8, 643-649.
42. León, H., Shibata, M. C., Sivakumaran, S., Dorgan, M., Chatterley, T., and Tsuyuki, R. T. (2008). Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337, a2931.
43. Liu, T., Korantzopoulos, P., Shehata, M., Li, G., Wang, X., and Kaul, S. (2011). Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 97, 1034-1040.
44. Macchia, A., Monte, S., Pellegrini, F., Romero, M., Ferrante, D., Doval, H., D'Ettorre, A., Maggioni, A. P., and Tognoni, G. (2008). Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur. J. Clin. Pharmacol. 64, 627-634.
45. Madsen, T., Christensen, J. H., Thøgersen, A. M., Schmidt, E. B., and Toft, E. (2010). Intravenous infusion of n-3 polyunsaturated fatty acids and inducibility of ventricular tachycardia in patients with implantable cardioverter defibrillator. Europace 12, 941-946.
46. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., Valagussa, F., and GISSI-Prevenzione Investigators. (2002). Early protection against sudden death by n3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nelĺ Infarcto Miocardio (GISSI)-Prevenzione. Circulation 105, 1897-1903.
47. Mariscalco, G., Sarzi Braga, S., Banach, M., Borsani, P., Bruno, V. D., Napoleone, M., Vitale, C., Piffaretti, G., Pedretti, R. F., and Sala, A. (2010). Preoperative n-3 polyunsaturated fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology 61, 643-650.
48. Mayyas, F., Sakurai, S., Ram, R., Rennison, J. H., Hwang, E. S., Castel, L., Lovano, B., Brennan, M. L., Bibus, D., Lands, B., Barnard, J., Chung, M. K., and Van Wagoner, D. R. (2011). Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. Cardiovasc. Res. 89, 852-861.
49. Metcalf, R. G., Sanders, P., James, M. J., Cleland, L. G., and Young, G. D. (2008). Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am. J. Cardiol. 101, 758-761.
50. Mitasíková, M., Smidová, S., Macsaliová, A., Knezl, V., Dlugosová, K., Okruhlicová, L., Weismann, P., and Tribulová, N. (2008). Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol. Res. 57(Suppl. 2), S39-S48.
51. Mozaffarian, D., Lemaitre, E. N., King, I. B., Song, X., Spiegelman, D., Sacks, F. M., Rimm, E. B., and Siscovick, D. S. (2011a). Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study. a cohort study. Ann. Intern. Med. 155, 160-179.
52. Mozaffarian, D., Marchioli, R., Gardner, T., Ferrazzi, P., O'Gara, P., Latini, R., Libby, P., Lombardi, F., Macchia, A., Page, R., Santini, M., Tavazzi, L., and Tognoni, G. (2011b). The ω-3 fatty acids for prevention of postoperative atrial fibrillation trial rationale and design. Am. Heart J. 162, 56-63.
53. Mozaffarian, D., and Wu, J. H. (2011). Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58, 2047-2067.
54. Neubronner, J., Schuchardt, J. P., Kressel, G., Merkel, M., von Schacky, C., and Hahn, A. (2011). Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur. J. Clin. Nutr. 65, 247-254.
55. Nodari, S., Metra, M., Milesi, G., Manerba, A., Cesana, B. M., Gheorghiade, M., and Dei Cas, L. (2009). The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc. Drugs Ther. 23, 5-15.
56. Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., and Dei Cas, L. (2011). n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 124, 1100-1106.
57. Park, Y., Lim, J., Lee, J., and Kim, S. G. (2009). Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br.J.Nutr. 102, 1355-1356.
58. Patel, D., Shaheen, M., Venkatraman, P., Armaganijan, L., Sanchez, J. E., Horton, R. P., Di Biase, L., Mohanty, P., Canby, R., Bailey, S. M., Burkhardt, J. D., Gallinghouse, G. J., Zagrodzky, J. D., Kozeluhova, M., and Natale, A. (2010). Omega-3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol. J. 9, 292-298.
59. Peltier, S., Louchami, K., Zhang, Y., Portois, L., Hacquebard, M., Malaisse, W. J., and Carpentier, Y. A. (2009). Alteration of lipid fatty acid profile and cationic fluxes in ventricular cardiomyocytes from omega3depleted rats. Int. J. Mol. Med. 24, 343-352.
60. Pottala, J. V., Garg, S., Cohen, B. E., Whooley, M. A., and Harris, W. S. (2010). Blood Eicosapentaenoic and docosahexaenoic acids predict allcause mortality in patients with stable coronary heart disease: the heart and soul study. Circ. Cardiovasc. Qual. Outcomes 3, 406-412.
61. Pratt, C. M., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., and Kowey, P. R. (2009). Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am.HeartJ.158, 163-169.
62. Raitt, M. H. (2009). Are n-3 polyunsaturated fatty acids antiarrhythmic in the absence of ischemia? Editorial to: "the role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" by S. Nodari et al. Cardiovasc. Drugs Ther. 23, 1-3.
63. Ramadeen, A., Connelly, K. A., LeongPoi, H., Hu, X., Fujii, H., Van Krieken, R., Van Laurent, G., Holub, B. J., Bazinet, R. P., and Dorian, P. (2012). N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria. Heart Rhythm. [Epub ahead of print].
64. Ramadeen, A., Laurent, G., dos Santos, C. C., Hu, X., Connelly, K. A., Holub, B. J., Mangat, I., and Dorian, P. (2010). n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm 7, 520-528.
65. Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., Worth, H., Katus, H., Spitzer,W., Sabin, G., Senges, J., and OMEGA Study Group. (2010). OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122, 2152-2159.
66. Rauch, B., Schiele, R., Schneider, S., Gohlke, H., Diller, F., Gottwik, M., Steinbeck, G., Heer, T., Katus, H., Zimmer, R., Erdogan, A., Pfafferott, C., Senges, J., and OmegaStudy Group. (2006). Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarctionaims and methods of the OMEGAstudy. Cardiovasc. Drugs Ther. 20, 365-375.
67. Richardson, E. S., Iaizzo, P. A., and Xiao, Y. F. (2011). Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids. J. Cardiovasc. Transl. Res. 4, 42-52.
68. Sala-Vila, A., Harris, W. S., Cofán, M., Pérez-Heras, A. M., Pintó, X., Lamuela-Raventós, R. M., Covas, M. I., Estruch, R., and Ros, E. (2011). Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br.J.Nutr. 106, 425-431.
69. Saravanan, P., Bridgewater, B., West, A. L., O'Neill, S. C., Calder, P. C., and Davidson, N. C. (2010). Omega3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, doubleblind, placebo-controlled clinical trial. Circ. Arrhythm. Electrophysiol. 3, 46-53.
70. Savelieva, I., Kakouros, N., Kourliouros, A., and Camm, A. J. (2011). Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 13, 610-625.
71. Schrepf, R., Limmert, T., Weber, P. C., Theisen, K., and Sellmayer, A. (2004). Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 363, 1441-1442.
72. Schuchardt, J. P., Neubronner, J., Kressel, G., Merkel, M., von Schacky, C., and Hahn, A. (2011). Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: results from a six month randomized controlled trial. Prostaglandins Leukot. Essent. Fatty Acids 85, 381-386.
73. Shearer, G. C., Pottala, J. V., Spertus, J. A., and Harris, W. S. (2009). Red blood cell fatty acid patterns and acute coronary syndrome. PLoS ONE 4, e5444. doi:10.1371/journal.pone.0005444
74. Shen, J., Johnson, V. M., Sullivan, L. M., Jacques, P. F., Magnani, J. W., Lubitz, S. A., Pandey, S., Levy, D., Vasan, R. S., Quatromoni, P. A., Junyent, M., Ordovas, J. M., and Benjamin, E. J. (2011). Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am. J. Clin. Nutr. 93, 261-236.
75. Skuladottir, G. V., Heidarsdottir, R., Arnar, D. O., Torfason, B., Edvardsson, V., Gottskalksson, G., Palsson, R., and Indridason, O. S. (2011). Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur. J. Clin. Invest. 41, 995-1003.
76. Smith, P. J., Blumenthal, J. A., Babyak, M. A., Georgiades, A., Sherwood, A., Sketch, M. H. Jr., and Watkins, L. L. (2009). Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. Am. J. Clin. Nutr. 89, 1315-1320.
77. Streppel, M. T., Ocké, M. C., Boshuizen, H. C., Kok, F. J., and Kromhout, D. (2008). Longterm fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur. Heart J. 29, 2024-2030.
78. Tsuburaya, R.,Yasuda, S., Ito,Y., Shiroto, T., Gao, J. Y., Ito, K., and Shimokawa, H. (2011). Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs. J. Mol. Cell. Cardiol. 51, 329-336.
79. Virtanen, J. K., Mursu, J., Voutilainen, S., and Tuomainen, T. P. (2009). Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120, 2315-2323.
80. Viviani Anselmi, C., Ferreri, C., Novelli, V., Roncarati, R., Bronzini, R., Marchese, G., Somalvico, F., Condorelli, G., Montenero, A. S., and Puca, A. A. (2010). Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J. Interv. Card. Electrophysiol. 27, 95-99.
81. von Schacky, C. (2008). Omega-3 fatty acids pro-arrhythmic, antiarrhythmic or both ? Curr. Opin. Clin. Nutr. Metab. Care 11, 94-99.
82. von Schacky, C. (2010). Omega-3 fatty acids vs. cardiac disease - the contribution of the omega-3 index. Cell. Mol. Biol. (Noisy-le-grand) 56, 93-101.
83. von Schacky, C. (2011). The omega-3 index as a risk factor for cardiovascular diseases. Prostaglandins Other Lipid Mediat. 96, 94-98.
84. Watanabe, E., Sobue, Y., Sano, K., Okuda, K., Yamamoto, M., and Ozaki, Y. (2011). Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation. Ann. Noninvasive Electrocardiol. 16, 373-378.
85. Wilhelm, M., Tobias, R., Asskali, F., Kraehner, R., Kuly, S., Klinghammer, L., Boehles, H., and Daniel, W. G. (2008). Red blood cell omega3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. Am.HeartJ.155, 971-977.
86. Wu, J. H., Lemaitre, R. N., King, I. B., Song, X., Sacks, F. M., Rimm, E. B., Heckbert, S. R., Siscovick, D. S., and Mozaffarian, D. (2012). Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 125, 1084-1093.
87. Xiao, Y. F., Sigg, D. C., Ujhelyi, M. R., Wilhelm, J. J., Richardson, E. S., and Iaizzo, P. A. (2008). Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 294, H2212-H2218.
88. Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., Shirato, K., and Japan EPA lipid intervention study (JELIS) Investigators. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090-1098.
89. Zeghichi-Hamri, S., de Lorgeril, M., Salen, P., Chibane, M., de Leiris, J., Boucher, F., and Laporte, F. (2010). Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemiareperfusion injury in rats. Nutr. Res. 30, 849-857.